GLP-1 Agonists Linked to Lower Mortality in Cancer Patients With Brain Metastases: JAMA Medha Baranwal20 March 2026 10:00 AM ISTUSA: A new study has shown that among cancer patients with brain metastases and type 2 diabetes, use of GLP-1 receptor agonists was associated with a...
MASLD in T2D: Why Weight Loss Is More Than Cosmetic? Dr. Kamal Kant Kohli10 March 2026 10:26 AM ISTIndia's diabetes burden is escalating rapidly, with 101 million adults currently living with T2DM (ICMR-INDIAB Study)1. Compounding this crisis,...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
NICE 2026 Updates Type 2 Diabetes Care: Cardiovascular Focus, Early SGLT-2 Use Takes Forefront Aditi Dhingra2 March 2026 12:30 PM ISTThe most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has...
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients: Study Dr. Kamal Kant Kohli27 Feb 2026 9:30 AM ISTIndividuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist...
Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal sheeba farhat21 Jan 2026 7:01 PM ISTMumbai: Global pharmaceutical major Lupin Limited on Tuesday announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings...
Tirzepatide Matches Dulaglutide for Cardiovascular Protection With Added Metabolic Benefits: NEJM Dr Riya Dave22 Dec 2025 11:00 AM ISTIn a large randomized trial involving patients with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide was...
Semaglutide Significantly Improves Glycemia and Weight in Schizophrenia: JAMA Dr Riya Dave19 Dec 2025 8:45 PM ISTAccording to a new study published in JAMA Psychiatry, adjunctive semaglutide was shown to significantly improve glycemic control and weight outcomes...
GLP-1 RA Therapy Slows Aortic Dilatation Progression in T2DM: Study Dr. Shravani Dali25 Nov 2025 8:15 PM ISTA new study by Celestino Sardu and colleagues, published in the International Journal of Molecular Sciences (2025), has found that therapy with...
ATTAIN-2 Trial: Oral GLP-1 Orforglipron Lowers Weight and HbA1c among diabetics with obesity Dr. Kamal Kant Kohli28 Aug 2025 12:00 PM ISTTopline results from the ATTAIN-2 trial have demonstrated that adults taking 36 mg orforglipron lost an average of 10.5% body weight at 72 weeks,...
Semaglutide Reduces Risk of Osteoporosis and Gout in Obese Type 2 Diabetes Patients: Study Dr Riya Dave30 May 2025 9:00 AM ISTResearchers have found in a new cohort study that semaglutide offers significant protection against osteoporosis and gout in individuals with obesity...
Semaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis: a case report Dr Kartikeya Kohli21 April 2025 9:00 AM ISTSemaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis suggests a case report published in the BMC...
